1- Avril J.L., Dabernat H., Denis F., Monteuil H. Les Neisseria. In Bactériologie Clinique, Ed : ellipses, Paris 1992 : 68-83.
2- Aborio M., Sall A. Surveillance epidémiologique de la gonococcie au Sénégal Rapport sur le fonctionnement technique de l'Institut Pasteur, Dakar, 1986, 23- 26.
3- Adegbola R. A., Sabally S., Corrah T., West B., Marbey D. Antimicrobial susceptibility and plasmid content of Neisseria gonorrhoeae isolated from the Gambia. 7th International Congres for Infectious Diseases, Hong Kong, June 1996, abstract N° 67007.
4- Barbe G., Babolat M., Boeufgras J M, Monget D. and Freney J. Evaluation of API NH, a new 2 Hours system for identification of Neisseria and Haemophilus Species and Moraxella catarrhalis in a routine clinical laboratory. J. Clin. Microbiol., 1994, 14(3) : 187-189. 5- Blazquez J., Baquero M. R., Canton R., Alos I., Baquero F. Characterization of a new TEM type β lactamase resistant to clavulate, sulbactam and tazobactam. Antimicrob. Agents and Chemoter, 1993 ; 37(10) : 2059-2063. 6- Brisson Y, Riou J Y, Labidi A., Arborio M, Guibourdenche M. A propos de gonocoques producteurs de β lactamases isolées à Dakar : Sensibilité à divers antibiotiques, auxotypes et contenu plasmidique. Path, Biol, 1985, 83 (N°5 bis) 550-55 7- Bruckner D.A., Colonna P. Nomenclature for aerobic and facultative bacteria. Clin. infect. Dis., 1993 ; 16 : 598-605. 8- Baquero F., Canton R., Beltran J.M. and Bolmström. The Etest an epidemiology tool. Diagnostic Microbiol Infect Deseases, 1992 ; 15 : 483-487. 9- Berche P., Gaillard J.L., Simonet M. Neisseria et espèces proches. Bactériologie clinique 2ème ed, Paris Flammarion, 1989, : 208-220. 10- Brunham C.R. Embree J.E. Current and future dimensions of the problem in the third world. In : Germain A., Holmes K.K, Piot P., Wasserheit J.N. Eds Plenum Press Reproductive tract infection. New York, , 1992 : 35-58 11- Courvarlin P., Trien-Cuot P. Plasmides et transposon de résistance aux antibiotiques. In : Le Minor L., Veron M. In Bactériologie Medicale 2ème ed, Médecine Science Flammarion, Paris 1989 : 316-331. 12- Camban E., Gutmann L. Mechanisms of resistance to quinolones Clinical Drug Invest, 1993 ; 45 (3) : 15-23.
13- Carbonelle B., Denis F., Marmonier A., Pinon G., VARGUES R. Sérodiagnostic des infections bacteriennes In Bacteriologie Medicale,2ème Ed, Paris, 1992 : 309-319. 14- Cremieux A.C. Infections gonococciques Rev. Prat, 1987 ; 37, (15), : 833-839. 15- Casin I., Perenet F., Issoire C., Mehouchy R., Riou J.Y, Morel P., Peroc Y. Apparition en France de Neisseria gonorrhoeae producteur de pénicillinase et resistant à haut niveau aux tétracyclines. Presse Med, 1990 ; 19 : 968.
16- Dillon J.A., Carballo M. Molecular epidemiology and novel combination of auxotype, serovar and plasmide content in tetracycline resistant Neisseria gonorrhoeae isolated in Canada. Can J. Microbiol. 1990 ; 36 (1) : 64-67
17- Esposito S., Noviello S. In vitro sensitivity of amoxicillin/acid clavulanic to isolated β lactamse and in- vitro antibacterial activity. J. Chemother, 1990 ; 2 (3) : 167-170. 18- Euright M.C., Carter P.E., Maclean I.A., Kenzie H. Phylogenitic relation ships between some members of the genes Neisseria, Acinetobacter, Moraxella and Kingella based on partial 16S ribosomal DNA sequence analysis. Intern J Syst bacteriol, 1994 ; 44, (4) : 316-342.
19- Garcia N. E., Moudragon-Jaimes V.A., Coude Gonzales C.J. Use of molecular biology in the epidemiological characterization of Neisseria gonorrhoeae. Salud publica de Mexico,1992 ; 34 (3) : 292-300. 20- Gutmann L., Kitzis MD., Acar J.F. Evolution of enzymatic mechanisms of resistance amoung β lactam antibiotics J. Intern. Med Res, 1990 ; 18 suppl 4 : 37-47. 21- Gotschlich E. C. Development of a gonorrhoeae vaccine prospects, strategy and technics Bull of the World Health Organisation (WHO), 1984 ; 62, N°5 : 671-680. 22- Goldstrein F., Jones R., LambertN. De la microbiologie à la clinique La lettre de l'infectiologue, 1994 ; N° hors série :3-7. 23- Gillride K. A., Bruntom J. L. Identification and characterization of a new replication region in the Neisseria gonorrhoeae β lactamase plasmid pFA3. J.Bacteriol. 1990 ; 172(5), : 243 24- Gascogne D.M., Heritage J., Hawkey P.M., Tuner A., Van Klingeren B. Molecular evolution of tetracycline resistance plasmids carrying T et M found in Neisseria gonorrhoeae from different countries J antimicrob chemother, 1991 ; 28(2) : 173-83. 9-2446. 25- Hitchnock P.A. Neisseria gonorrhoeae penicillin susceptibility a comparison of three testing methods Brith. J. Bio Med Science, 1993, 50 : 301-304.
26- Ison C.A. Terry P., Binday N., Gill N.J.; Adams J., Woodford N. Tetracycline resistant gonococci in the UK. Lancet, 1988; 651-652.
27- Ikeda F. Intrinsic penicillin resistance in penicillinase producing Neisseria gonorrhoeae strains Microbiol Immunol, 1990 ; 34(1) : 1-9.
28- Konl P.K;, Geraud G.P., Piotrowski H.D., Petzoldt D., High level tetracycline resistance of Neisseria gonorrhoeae Hauterzt 1990 ; 41(8) : 438-41. 29- Koeck J.L., Cavallo J.D, Crenn and Meyran D. Intérêt du Etest dans la determination de la sensibilité aux antibiotiques de Neisseria gonorrhoeae. RICAI, Paris, 1993 30- Lynne J., Dome B., and Bernard M., Prigeent MD. Epidemiology of β lactamase in Africa : correlation with resistance to β lactam antibiotics. Clinical therapeutic, 1991 ; 13, N°2. 31- Le Faou A ., I Guy, P. Klut, JC Tardieu Intérêt du cefotaxime dans le traitement du portage asymptomatique de gonocoque chez la femme. Nouv. Presse. Med., 1981 ; 549-552. 32- Lefevre J.C., E. Lambert, Lareng M.B., Premier isolement en France d'une souche de Neisseria gonorrhoeae non NGPP et presentant un haut niveau à la tetracycline Path, Biol 1991 ; 39, N°5 : 491-494. 33- Limberger J. R., Bicgar R., Evanloe A., Mac Carthyll, Slivienski L, Kirkwood M. Evaluation of culture and gene probe pace assay for detection of Neisseria gonorrhoeae and Chlamydia trachomatis in endocervical specimen transported to a state health laboratory J clin Microbiol, 1992, 30 (5) : 1162-1166. 34- Morello A. J., Janda N.W. and Doern G.R. Neisseria and Branhanella. In : Lennette E.H., Balloow A., William J., Shadomy J.H., eds. Manual Clin Microbiol, Washington, 1991 : 258-276. 35- Morse S.A, Johnson SR, Biddle J.W. and Roberts N.C. High level tetracycline in Neisseria gonorrhoeae in result of Acquisition of Streptococcal T et M Determinant Antimicrob Agents and chemother, 1986 : 664-670. 36- Martha L Sanchez and Ronald N. Jones. Etest an antimicrobial susceptibility testing method with broad clinical and epidemiological application. The Antimicrobic News letter, 1993 ; 8, N°1 : 1-9.
37- Milan S., Blake and Lee M. Wetzler Vaccine for gonorrheae : where are we on the curve ? virulence, infections and pathogenesis trends in microbiology, 1995 ; 3, N°12 : 69-73. 38- Meyran M. et Thabaut A. Neisseria et antibiotiques. In : Corvarlin P., Golstein F., Philipon A., Sirot J., eds l'antibiogramme 1ère éd, Paris : MPC-Videon, 1985 : 73-79. 39- Meyran M. et Thabaut A. Neisseria et antibiotiques. In : Couvarlin P., Golstein F., Philipon A., Sirot J., eds l'antibiogramme 1ère éd, Paris : MPC-Videon, 1985 : 73-79. 40- Mboup S., Boye C.S., Bathily C.T., Sensibilité des souches de gonocoques isolées à Dakar, 1995, Symposium Kampala. 41-Mboup S., Boye C.S., Dieng Sarr A., Samb N.D., Ouangre A.R. Guide du laboratoire pour le traitement des MST Comité National de Prévention du Sida Laboratoire de Bactériologie Virologie HALD, 1993 ; 2-5. 42- Noran J.S. and Levine W.C. Drugs of choice for the treatement of uncomplicated gonococcal infection. Clin. Infect. Dis., 1995 ; 20 : 47-65.
43- National Committee for Clinical Laboratory Standard.(NCCLS) Mininum inhibitory concentration (MIC) interpretive standard (µg/ml) for Neisseria gonorrhoeae. NCCLS, Vilanova, Pa 1983. Bull. Soc. Path. Ex., 1994 ; 14, N°16 44- Niasse M.F. Etude de l'effet inoculum sur la variation de la sensibilité des germes aux antibiotiques Thèse Pharmacie. 1995 ; N°17.
45- Riou J.Y. Famille des Neisseriaceae Cours de microbiologie systématique Institut Pasteur Paris, 1986. 46- Roberts M.C., Van Klinge Ren B., Knapp J.S. Tet and β-lactamase containing Neisseria gonorrhoeae (tetracycline resistant and penicillinase producing) in the Netherlands. Antimicrob Agents and chemoter 1988, 32 ; 158. 47- Riou J.Y., Martin P., Guibomdenche M. Antibiotic susceptibility of penicillinase producing N. gonorrhoeae strains isolated in France. J antimicrob chemother, 1985, 16 Suppl. A. 209-212. 48- Riou J.Y., Prerem E., Peany, Ghasia J.C. et Coll. Caractéristiques des souches de N. gonorrhoeae productrices de pénicillinase isolées en France de 1979 à 1986. Path. Biol. 1987, 35 ,N°5 : 791-795. 49- Riou J.Y., Courten A.L. Neisseria, Branhamella, Moraxella In :: Le Minor, Veron M. In Bacteriologie Médicale Paris Flammarion, 1982 : 409-433.
50- Sexually Transmitted Diseases Global Programme on AIDS, Organisation Mondiale de la Santé, 1995, R : 1921. 51- Sanchez M. L., Barett S.M. and Jones N.R. The Etest applied to susceptibility test of gonococci multiply-resistant, Enterococci and Enterobactericeae producing potent β lactamase Microbiology and infections Diseases, 1992 ; 15 : 459-463. 52-Sanchez L.M., Jones N.R. Applications of the Etest technology : Drug susceptibility testing and epidemiology. Special Microbiology antiinfectious Research Center,1992 ; 1, N°2 53- Sarafian S. K., Genco C.A., Robert M.C., KNAPP J.S. Aquisition of beta-lactamase and Tet M containing conjugative plasmids by phenotypically differents strain of Neisseiria gonorrhoeae. Sexually Transmitted Diseases, 1990 ; 17(2) : 67-71.
54- Siboulet A., Coulaud J.P. et coll. Blenorragies gonococciques. In : Les Maladies sexuellement transmissibles. Paris 1991, Ed Masson : 105- 157.
55- Siboulet A., F. Catalan Localisation non génitales de la gonococcie Méd et Mal Infect 1979 ; 268 : 276. 56- Siboulet A., Pr J. P Coulaud, Dr. F. Catalan, P. Sednaoui Les MST L'objectif médical, 1992 ; N° 96 : 9-20. 57- Thomson C.I., Amyes S.G. Emergence of a clavulanic acid resistant TEM β lactamase in a clinical strain. Microbiology letter, 1992 ; 70 (20) : 113-7. 58- Van Dick E., Catalan F., Peter P., Meheus A. Directives de laboratoires applicables aux diagnostics des maladies sexuellement transmissibles OMS 1989. Programme MST, OMS, 1989, pp590.
59- Van Dick E., Hilde S., Peter P. Comparison of Etest with agar dilution for antimicrobiol susceptibility testing of N. Gonorrhoeae A.S.M. 1994 ; 32 (6) : 1586-1588. 60- Van Dick E., Rousseau R., Duhamel M. et Coll., Tetracycline resistance in Central Africa Genitourinary Medecine 1988, 1992, 1994, 68 (2) ; 111-116.
61- Van Dick E. Antimicrobial MIC interpretive standard and break point for susceptibility and resistance for N. gonorrhoheae. Institute of Tropical Medecine, 1995 ; 13 :07
62- Van Hall M.A., Petit P.L., Van Hall N., Mouton R.P., Ndinya Achola J.O. Prevalence of resistance of Neisseria gonorrhoeae to penicillin and three other antibiotics in a rural area in Kenya. East African Medical Journal Nov 1991, 68(11) : 853-9. 63- Vazquez J.A., Berron S., Mendez B. Isolate of T et M containing Neisseria gonorrhoeae (TRNG) in Spain. Genitourinary Med., 1990 ; 66 : 303-304. 64- Warren C., Philipps I. Penicillinase producing Neisseria gonorrhoeae from St Thomas hospital 1976- 1990. Genitourinary Medicine, 1993 ; 69 (3) : 207-7.
65- Zenilman J.M., Neumann T., Patton M., Reichart C. Antibacterial activities of OPC-17116, ofloxacin and ciprofloxacin against 200 isolates of Neisseria gonorhoeae. Antimicrob Agents and chemother,1993 ; 37 (10) : 2244-6.
Food Allergy/Restrictive Diet Form If your child has food-related allergies, it is required that the family discusses the allergies with our cook and your child’s classroom teacher prior to their first day of enrollment. If the food allergy is not life threatening, the parent may substitute a like item for the allergy food. The family must also provide substitutions for religio
MALE PANEL Common Hormone Conditions BREAST ENLARGEMENT Interactions between the four hormones of the Men who carry extra weight around the middle male panel (see Page 3) are fundamental to have more of the enzyme aromatase, which health, so hormone imbalances may negatively converts testosterone to estrogen. Increased impact health. The following are examples of how estrogen can